Business Standard

Blackstone, Baring in race to acquire up to 20% stake in pharma firm Cipla

Cipla shares closed 9.6 per cent up on Thursday to Rs. 1,175

Cipla
Premium

Dev ChatterjeeSohini Das Mumbai

Listen to This Article

In one of the largest potential transactions this year, private-equity majors Blackstone and Baring have initiated talks with the Hamied family, the promoters of pharmaceutical firm Cipla, to acquire up to 20 per cent in the company.
 
The family owns 33.47 per cent and may become minority owners if the talks succeed, said a source close to the development.
It has appointed bankers to seek bids from potential investors, and Blackstone and Baring PE have responded.
“There is 15-20 per cent which is on the block by the family and a decision is expected soon,” said the source, asking not to be

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 27 2023 | 9:47 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com